Wells Fargo NVIDIA · NVDA

Wells Fargo Reaffirms Overweight on NVIDIA, $300 Price Target

Analyst: Matt Bryson 1 min read Reproduced verbatim
Rating
Overweight
Unchanged
Target
$300
Unchanged
Upside
+87%
NVDA at $160 today

9th-highest of 32 current targets on NVIDIA, 15% above the $260 median. Wells Fargo has reached 67% of its year-old targets (36 scored).

Wells Fargo and NVIDIA logos

What the analyst said

Wells Fargo analyst Matt Bryson reiterated an Overweight rating and $300 price target on NVIDIA (NASDAQ: NVDA).

“We view Mr. Huang’s resignation as a step closer to a clearing event for shares, though we see investigation re: potential national security concerns remaining a risk.

That said, we see little risk to demand destruction and remain confident in ests. News: CEO Jensen Huang resigned as President, CEO, and member of the board, effective immediately. Current CFO Colette Kress has agreed to serve as Interim CEO while maintaining her CFO position, and the board has initiated a search for a permanent CEO—considering internal & external candidates.

Harvey C. Jones named Chair of the board. This follows last night’s news that NVIDIA’s board was preparing to remove Mr. Huang after reports of a second extramarital relationship with a direct report. NVIDIA reconfirmed its F3Q27 earnings date of 11/17.

We would re-highlight our prior (11/11) note – CEO Change Looking Increasingly Likely; Key Topics of Investor Discussions, and F3Q27 NVIDIA preview – Thoughts into F3Q27 – Expecting Solid Beat / Raise; Focus on Supply Chain Scale & Forward Visibility.

We continue to believe NVIDIA’s significant supply chain scale, supplier investments / relationships, & impressive efficiency / throughput gains remain a key competitive differentiation. While Mr. Huang has played a key role in cultivating this, we think it can be sustained following a CEO transition. As such we are confident in our growth and share estimates for NVIDIA.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

NVDA trades at $160. The 32 analysts who set a target in the last 3 months range from $170 to $515, with a median of $260. This $300 target is 15% above the median.

12-month window: day 0 of 365, closes on November 13, 2027.

Track record

This callOpen: NVDA has not reached $300 yet. This 12-month target is scored on November 10, 2027. Same target as this firm’s November 10, 2026 note, so it is scored there.

Firm track recordWells Fargo: 67% of its 36 targets at least a year old were reached within 12 months (#20 of 26 firms); on NVIDIA, 3 of 3. Accuracy ranking →

Wells Fargo on NVIDIA

Wells Fargo price targets on NVIDIA

6 calls from December 9, 2025 to November 13, 2026. The target went from $265 to $300 (+13%). The rating stayed Buy.

Wells Fargo targetNVDA share price
  1. November 13, 2026 This noteKept the $300 targetBuy$300
  2. November 10, 2026Target cut from $315 (−5%)Buy$300
  3. August 11, 2026Kept the $315 targetBuy$315
  4. May 12, 2026Target raised from $265 (+19%)Buy$315
  5. December 29, 2025Kept the $265 targetBuy$265
  6. December 9, 2025Earliest call shownBuy$265
Share

Other analysts on NVIDIA

HSBCHold Downgraded Nov 13 $170 KeyBancHold Kept ratingReiterated Nov 13 NeedhamBuy Cut price target −33%, kept ratingCut target Nov 13 $200from $300−33% BarclaysBuy Cut price target −24%, kept ratingCut target Nov 13 $210from $275−24% TruistHold Downgraded Nov 12 $174
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.